Cytotoxic drug therapy in steroid-resistant glomerulonephritis.
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use*; D001706:Biopsy; D001797:Blood Protein Electrophoresis; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004361:Drug Tolerance; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D003520:Cyclophosphamide; D001379:Azathioprine